← Back to Search

Acupuncture for Postoperative Pain in Cancer Surgery

N/A
Waitlist Available
Led By Lorenzo Cohen
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Undergoing open gastrointestinal cancer resection (pancreatic or colorectal)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights

Study Summary

This trialis exploring if acupuncture can help reduce pain and other symptoms after open colorectal or pancreatic surgery. It may lead to better recovery and fewer side effects.

Who is the study for?
This trial is for English-speaking patients with pancreatic or colorectal cancer who are undergoing open surgery. They must be able to consent and follow the study's rules. People using high doses of opioids, those with bowel obstruction, recent major surgery, seizures, cognitive issues, or conditions preventing acupuncture can't join.Check my eligibility
What is being tested?
The study is testing if acupuncture can manage pain after pancreatic or colorectal surgery better than usual care practices. Patients will receive acupuncture therapy alongside standard postoperative procedures and their pain levels will be monitored through questionnaires.See study design
What are the potential side effects?
Acupuncture may cause minor side effects such as slight bleeding, bruising at needle sites, nausea, or dizziness. Most people find it a low-risk procedure that doesn't have serious complications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am having surgery for pancreatic or colorectal cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence rate to daily acupuncture
Compliance
Retention
Secondary outcome measures
Pain levels
Postoperative opioid use for pain management
Satisfaction of pain control
Other outcome measures
Dietary recovery
Postoperative length of stay

Side effects data

From 2022 Phase 2 trial • 45 Patients • NCT04496219
62%
Urinary Symptoms
58%
Fatigue
38%
Headache
35%
Hematuria
35%
Bowel Symptoms
35%
Flu-like Symptoms
31%
Other
27%
Pain
4%
Bruise
100%
80%
60%
40%
20%
0%
Study treatment Arm
Arm I (Acupuncture, BCG)
Arm II (BCG, Standard of Care)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (acupuncture, usual care)Experimental Treatment3 Interventions
Beginning the day after surgery, patients undergo acupuncture sessions over 25 minutes QD for up to 7 days. Patients also undergo usual care including preoperative visits to the primary surgical team, anesthesia preoperative evaluation, referrals to other specialties for perioperative evaluation and optimization of comorbid conditions if necessary, surgical operations, postoperative hospitalization, and post-discharge clinic visits.
Group II: Arm II (usual care)Active Control2 Interventions
Patients undergo usual care including preoperative visits to the primary surgical team, anesthesia preoperative evaluation, referrals to other specialties for perioperative evaluation and optimization of comorbid conditions if necessary, surgical operations, postoperative hospitalization, and post-discharge clinic visits.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acupuncture Therapy
2018
Completed Phase 2
~130

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,967 Previous Clinical Trials
1,804,732 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,597 Total Patients Enrolled
Lorenzo CohenPrincipal InvestigatorM.D. Anderson Cancer Center
11 Previous Clinical Trials
58,224 Total Patients Enrolled

Media Library

Digestive System Cancer Research Study Groups: Arm I (acupuncture, usual care), Arm II (usual care)
Digestive System Cancer Clinical Trial 2023: Acupuncture Therapy Highlights & Side Effects. Trial Name: NCT04560712 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for the trial still ongoing?

"The information posted on clinicaltrials.gov suggests that this specific trial is not presently enrolling patients, even though the last update was made in October 6th 2022. However, there are 4216 other trials open for recruitment at present."

Answered by AI
~22 spots leftby Dec 2025